-
1 Comment
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.2.
Based on the above factors, Talis Biomedical Corporation Common Stock gets an overall score of 1/5.
| CurrencyCode | USD |
|---|---|
| ISIN | US87424L1089 |
| Exchange | PINK |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 3M |
|---|---|
| PE Ratio | None |
| Target Price | 5 |
| Beta | 1.33 |
| Dividend Yield | None |
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TLIS using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
